三公开船棋牌游戏www.eth108.vip)(三公大吃小)是用以太坊区块高度哈希值开奖的棋牌游戏,有别于传统三公开船(三公大吃小)棋牌游戏,三公开船游戏(三公大吃小)游戏绝对公平,结果绝对无法预测。三公开船棋牌游戏(三公大吃小)由玩家PK,平台不参与。

KUALA LUMPUR: UMediC Group Bhd, which is slated for listing on Bursa Malaysia’s ACE Market on July 26, aims to raise RM31.11 million from its initial public offering (IPO).

The distributor and manufacturer of medical consumables products will allocate RM3.5 million from the gross proceeds to construct a new factory, RM6.8 million to set up new marketing and distribution offices in Kuala Lumpur and Johor, RM9 million for repayment of borrowings, and RM8.66 million for working capital.

Executive director and chief executive officer Lim Taw Seong said it is timely for the group to scale up its business to ride on the growth of Malaysia’s medical device industry, which is expected to record a compound annual growth rate of 12.1 per cent, from RM12.11 billion in 2021 to RM21.41 billion in 2026.

He said the growth is expected to be driven mainly by pent-up demand for medical devices from the medical tourism industry as well as existing and new hospitals.

‘’Most importantly, in light of our manufactured medical consumables, we are seeing an increasing awareness of using disposable medical products to reduce the risks of cross-contamination, especially after the pandemic.

‘’Therefore, our management team foresees a huge untapped potential and we are poised to seize these valuable opportunities,’’ he said during the launch of the prospectus for its IPO today.

UMediC produces HydroX Prefilled Humidifier and AirdroX Spacer Anti-Static Valved Inhaler Chamber, which currently contributes 20 per cent to its total revenue.

,

皇冠足球平台开户www.hg108.vip)是皇冠体育官网线上开户平台。皇冠足球平台开户面向亚太地区招募代理,开放皇冠信用网代理申请、皇冠现金网代理会员开户等业务。皇冠足球平台开户可下载皇冠官方APP,皇冠APP包括皇冠体育最新代理登录线路、皇冠体育最新会员登录线路。

,

Eighty per cent of revenue is generated from the distribution segment for products including defibrillators, ventilators, ultrasound machines, furniture, and maternal and infant care.

In the near future, the company targets to grow its medical consumables business’ contribution to revenue to 50 per cent by introducing more new products and increase production capacity.

Lim said the construction of a new factory in Batu Kawan with a built-up area of 35,000 square feet would support the upcoming commercialisation of its new products such as sterile water for inhalation, digital oxygen flowmeters, prefilled nebulisers, and humidity sensors.

The new facility will also support the production expansion of its HydroX and AirdroX series.

Legal and corporate adviser Ng Sze Hui said that once completed, the plant would double the company’s production to 600,000 units from 300,000 units monthly, which is expected to be achieved next month.

She said UMediC distributes its products to more than 30 countries.

Meanwhile, UMediC’s IPO comprises a public issue of 97.22 million new shares at 32 sen per share, out of which 18.69 million shares will be made available to the Malaysian public and 13.08 million shares allocated to eligible directors, employees and business associates, which have contributed to the success of the company.

ag区块链百家乐声明:该文看法仅代表作者自己,与www.allbetgame.us无关。转载请注明:三公开船棋牌游戏(www.eth108.vip):ACE Market-bound UMediC aims to raise RM31.11mil from IPO
发布评论

分享到:

Telegram游戏(www.tel8.vip):北京朝阳:持续关注核酸检测需求,优化点位设置,方便市民检测
1 条回复
  1. 皇冠投注平台出租(www.hg108.vip)
    皇冠投注平台出租(www.hg108.vip)
    (2022-12-05 00:10:18) 1#

    还好啦。

发表评论

◎欢迎参与讨论,请在这里发表您的看法、交流您的观点。